Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03495011 · ClinicalTrials.gov registry record
MRI Characterization of Mammographically Detected DCIS
A clinical trial of Breast Cancer Stage 0, sponsored by University of Washington.
- Active
- Registry status
- 122
- Enrollment target
- 1
- Study location
NCT03495011: Active study of Breast Cancer Stage 0, sponsored by University of Washington.
NCT03495011 is a study of Breast Cancer Stage 0 that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 122 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03495011, a study of Breast Cancer Stage 0, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- 122 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single institution, prospective observational clinical trial for women with mammographically identified calcifications that may represent ductal carcinoma in situ (DCIS). The purpose of this study is to determine whether quantitative, multiparametric breast MRI performed prior to surgical resection can biologically characterize this common pre-invasive malignancy, ductal carcinoma in situ (DCIS), which typically presents in asymptomatic women as suspicious calcifications on mammography.
Primary Outcome
Assess whether high f within DCIS lesions correlates with proliferation (high Ki-67)
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- DIAGNOSTIC_TEST Breast MRI
Study Locations (1)
Washington
- Fred Hutch/University of Washington Cancer Consortium - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2018-04-20 |
| Est. Completion | 2032-04 |
What the registry record for NCT03495011 still lists
NCT03495011 is an observational study that tracks outcomes without assigning an intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Breast Cancer Stage 0 appearing as the primary indexed condition, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT03495011 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT03495011 about?
NCT03495011 is a clinical study titled "MRI Characterization of Mammographically Detected DCIS". This is a single institution, prospective observational clinical trial for women with mammographically identified calcifications that may represent ductal carcinoma in situ (DCIS). The purpose of this study is to determine whether quantitative, multiparametric breast MRI performed prior to surgical...
What is the current status of trial NCT03495011?
This trial is currently active not recruiting. The enrollment target is 122 participants. The study started on 2018-04-20. Estimated completion is 2032-04.
What conditions does trial NCT03495011 study?
This clinical trial studies the following conditions: Breast Cancer Stage 0.
What interventions are being tested in trial NCT03495011?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Breast MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03495011?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03495011 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Stage 0
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03363373 · 122 participants · Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
- NCT03463954 · 122 participants · NA
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
- NCT04503265 · 122 participants · Phase 1
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- NCT04700527 · 122 participants · Phase 1
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI